Literature DB >> 28848156

Gender Differences of Nonmotor Symptoms Affecting Quality of Life in Parkinson Disease.

Jee-Eun Yoon1, Ji Sun Kim, Wooyoung Jang, Jinse Park, Eungseok Oh, Jinyoung Youn, Suyeon Park, Jin Whan Cho.   

Abstract

BACKGROUND/AIMS: Gender differences of health-related quality of life (HRQoL) in patients with various disorders have been reported. Various nonmotor symptoms (NMSs) also affect the patients' lives and HRQoL, even in the early stages of Parkinson disease (PD). Our study aimed to identify whether there are gender differences of HRQoL in PD patients in the early stages, and which NMSs are associated with HRQoL depending on gender.
METHOD: Eighty-nine PD patients (47 males, 42 females) and 36 healthy controls were enrolled. We evaluated HRQoL, NMSs, and their associations in each gender. RESULT: The total Parkinson Disease Quality of Life Questionnaire and Beck Anxiety Inventory scores were higher in female patients than in male patients. The correlation analysis revealed no association between NMSs and HRQoL in male patients. In female patients, HRQoL was highly correlated with depression, and moderately associated with fatigue.
CONCLUSIONS: Gender differences of an association between HRQoL and NMSs exist in PD. We found that fatigue and depression were the main determinants of poor HRQoL in female patients even in the early stages. We suggest that a gender-specific therapeutic approach is important, and it is necessary to pay special attention to the predictors associated with causing poor HRQoL.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Depression; Fatigue; Nonmotor symptoms; Parkinson disease; Quality of life; Sex differences

Mesh:

Year:  2017        PMID: 28848156     DOI: 10.1159/000479111

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  10 in total

1.  The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Authors:  Marissa Giovanna Schamne; Josiel Mileno Mack; Morgana Moretti; Filipe Carvalho Matheus; Roger Walz; Laurence Lanfumey; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2018-05-28       Impact factor: 3.911

Review 2.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

3.  Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease.

Authors:  Meredith A Bock; Ethan G Brown; Li Zhang; Caroline Tanner
Journal:  Neurology       Date:  2022-04-13       Impact factor: 11.800

4.  The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson's Disease Patients.

Authors:  Dong-Woo Ryu; Joong-Seok Kim; Sang-Won Yoo; Yoon-Sang Oh; Kwang-Soo Lee
Journal:  J Mov Disord       Date:  2019-08-09

5.  Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies.

Authors:  Na Zhao; Yuan Yang; Ling Zhang; Qinge Zhang; Lloyd Balbuena; Gabor S Ungvari; Yu-Feng Zang; Yu-Tao Xiang
Journal:  CNS Neurosci Ther       Date:  2020-12-28       Impact factor: 5.243

Review 6.  Gender Differences and Quality of Life in Parkinson's Disease.

Authors:  Pietro Crispino; Miriam Gino; Elena Barbagelata; Tiziana Ciarambino; Cecilia Politi; Immacolata Ambrosino; Rosalia Ragusa; Marina Marranzano; Antonio Biondi; Marco Vacante
Journal:  Int J Environ Res Public Health       Date:  2020-12-29       Impact factor: 3.390

7.  Predictors of clinically significant quality of life impairment in Parkinson's disease.

Authors:  Diego Santos García; Teresa de Deus Fonticoba; Carlos Cores; Guillermo Muñoz; Jose M Paz González; Cristina Martínez Miró; Ester Suárez; Silvia Jesús; Miquel Aguilar; Pau Pastor; Lluis Planellas; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Inés Legarda; Jorge Hernández Vara; Iria Cabo; Luis López Manzanares; Isabel González Aramburu; María A Ávila Rivera; Maria J Catalán; Víctor Nogueira; Víctor Puente; María Ruíz de Arcos; Carmen Borrué; Berta Solano Vila; María Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo Padilla; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Maria G Alonso Losada; Nuria López Ariztegui; Itziar Gastón; Pedro Clavero; Jaime Kulisevsky; Marta Blázquez Estrada; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Mónica Kurtis; Oriol de Fábregues; Jessica González Ardura; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir
Journal:  NPJ Parkinsons Dis       Date:  2021-12-16

8.  The quality of life in patients with Parkinson's disease: Focus on gender difference.

Authors:  Detao Meng; Zhaohui Jin; Lei Gao; Yixuan Wang; Ruidan Wang; Jinping Fang; Lin Qi; Yuan Su; Aixian Liu; Boyan Fang
Journal:  Brain Behav       Date:  2022-02-09       Impact factor: 2.708

9.  Sex Differences in Parkinson's Disease: From Bench to Bedside.

Authors:  Maria Claudia Russillo; Valentina Andreozzi; Roberto Erro; Marina Picillo; Marianna Amboni; Sofia Cuoco; Paolo Barone; Maria Teresa Pellecchia
Journal:  Brain Sci       Date:  2022-07-13

10.  Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat.

Authors:  Mounia Rahmani; Maria Benabdeljlil; Fouad Bellakhdar; Mustapha El Alaoui Faris; Mohamed Jiddane; Khalil El Bayad; Fatima Boutbib; Rachid Razine; Rachid Gana; Moulay R El Hassani; Nizar El Fatemi; Meryem Fikri; Siham Sanhaji; Hennou Tassine; Imane El Alaoui Balrhiti; Souad El Hadri; Najwa Ech-Cherif Kettani; Najia El Abbadi; Mourad Amor; Abdelmjid Moussaoui; Afifa Semlali; Saadia Aidi; El Hachmia Ait Benhaddou; Ali Benomar; Ahmed Bouhouche; Mohamed Yahyaoui; Abdeslam El Khamlichi; Abdessamad El Ouahabi; Rachid El Maaqili; Houyam Tibar; Yasser Arkha; Adyl Melhaoui; Abdelhamid Benazzouz; Wafa Regragui
Journal:  Front Neurol       Date:  2018-07-31       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.